
Health clinics that service immigrants are making house calls on patients too afraid to leave home
St. John's Community Health, one of the largest nonprofit community healthcare providers in Los Angeles County that caters to low-income and working-class residents, launched a home visitation program in March after learning that patients were missing routine and urgent care appointments because they feared being taken in by U.S. Immigration and Customs Enforcement agents.
St. John's, which offers services through a network of clinics and mobile units across the region, estimates that at least 25,000 of its patients are undocumented, and about a third of them suffer from chronic conditions, including diabetes and hypertension, which require routine checkups. But these patients were missing tests to monitor their blood sugar and blood pressure, as well as appointments to pick up prescription refills.
Earlier this year, the health center began surveying patients and found that hundreds were canceling appointments 'solely due to fear of being apprehended by ICE.'
President Trump came into his second term promising the largest deportation effort in U.S. history, initially focusing his rhetoric on undocumented immigrants who had committed violent crimes. But shortly after he took office, his administration said they considered anyone in the country without authorization to be a criminal.
In the months since, the new administration has used a variety of tactics to sow fear in immigrant communities. The Department of Homeland Security has launched an ad campaign urging people in the country without authorization to leave or risk being rounded up and deported. Immigration agents are showing up at Home Depots and inside courtrooms, in search of people in the U.S. without authorization. Increasingly, immigrants who are detained are being whisked away and deported to their home countries — or, in some cases, nations where they have no ties — without time for packing or family goodbyes.
The Trump administration in January rescinded a policy that once shielded sensitive locations such as hospitals, churches and schools from immigration-related arrests.
In response to the survey results, St. John's launched the Health Care Without Fear program in an effort to reach patients who are afraid to leave their homes. Jim Mangia, chief executive and president of St. John's, said in a statement that healthcare providers should implement policies to ensure all patients, regardless of immigration status, have access to care.
'Healthcare is a human right — we will not allow fear to stand in the way of that,' he said.
Bukola Olusanya, a nurse practitioner and the regional medical director at St. John's, said one woman reported not having left her home in three months. She said she knows of other patients with chronic conditions who aren't leaving their house to exercise, which could exacerbate their illness. Even some immigrants in the U.S. legally are expressing reservations, given news stories about the government accusing people of crimes and deporting them without due process.
Olusanya said waiting for people to come back in for medical care on their own felt like too great a risk, given how quickly their conditions could deteriorate. 'It could be a complication that's going to make them get a disability that's going to last a lifetime, and they become so much more dependent, or they have to use more resources,' she said. 'So why not prevent that?'
On a recent Thursday at St. John's Avalon Clinic in South L.A., Olusanya prepared to head to the home of a patient who lived about 30 minutes away. The Avalon Clinic serves a large population of homeless patients and has a street team that frequently uses a van filled with medical equipment. The van is proving useful for home visits.
Olusanya spent about 30 minutes preparing for the 3 p.m. appointment, assembling equipment to draw blood, collect a urine sample and check the patient's vitals and glucose levels. She said she has conducted physical exams in bedrooms and living rooms, depending on the patient's housing situation and privacy.
She recalled a similar drop in patient visits during Trump's first administration when he also vowed mass deportations. Back then, she said, the staff at St. John's held drills to prepare for potential federal raids, linking arms in a human chain to block the clinic entrance.
But this time around, she said, the fear is more palpable. 'You feel it; it's very thick,' she said.
While telehealth is an option for some patients, many need in-person care. St. John's sends a team of three or four staff members to make the house calls, she said, and are generally welcomed with a mix of relief and gratitude that makes it worthwhile.
'They're very happy like, 'Oh, my God, St. John's can do this. I'm so grateful,' ' she said. 'So it means a lot.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hill
2 hours ago
- The Hill
CDC funding changes inject ‘chaos' into local health programs
The Trump administration has delayed or blocked millions of dollars in federal grants from the Centers for Disease Control and Prevention (CDC), leaving state and local health departments in the dark, uncertain when or even if they will get money that's already been appropriated by Congress for key public health initiatives. With little communication from the White House, CDC staff are trying to expedite getting grants out the door, and public health officials are scrambling to spend the money they have before it expires Sept. 30. The CDC typically doles out the money it receives from Congress to state and local health departments, which in turn fund local contracts. But with the start of the new administration, the White House began to apportion money to CDC on a month-by-month basis, citing the need for external reviews. That practice stopped when the agency received a two-month apportionment through the end of the fiscal year, according to CDC employees, but some grants were delivered late while others are still being blocked. 'Everything is weeks, if not months behind schedule,' a CDC employee with knowledge of the funding situation said. Another employee noted the extra layers involved in getting funding out the door, including new external reviews being conducted by the U.S. Department of Government Efficiency (DOGE). 'With every single award requiring DOGE review, there is fear the award may not be made before the end of the fiscal year and lapse of funds,' the employee said. Raynard Washington, director of the Mecklenburg County Public Health Department in North Carolina, said his agency laid off six workers — including half its disease investigators — after grants for HIV prevention and surveillance programs expired at the end of May with no information about future funding. The grants were eventually restored about a month later, but to date the department has only been able to bring back half of the people it laid off. 'So now we're behind, and cases are still being reported every day that have to be investigated,' Washington said. 'The more time that people may have been exposed to HIV and don't know it, or syphilis and don't know it and are getting tested and treated, those delays actually translate to potential illness.' Meanwhile, the Trump administration is preventing CDC from funding tens of millions of dollars in other awards, including for public health emergency preparedness, chronic disease prevention and education, academic prevention research centers, gun violence, and tobacco use. That means activities like training hospital staff and other health workers alongside first responders to prepare for a natural disaster are on hold. Washington said North Carolina had to lay off its team working on tobacco prevention efforts because the funding had dried up. 'These are not delays that we expect, given that Congress has appropriated funding for these initiatives,' Washington said. 'And these are things that — despite the political swings in Washington — have largely received bipartisan support, and so you don't expect that there was going to be gaps.' Philip Huang, director of Dallas County Health and Human Services in Texas, said he was waiting for nearly 30 percent of the promised award for public health emergency preparedness. The state doesn't know if that money is ever coming, Huang said. 'So, it makes it very difficult for us to plan. And many health departments don't have much buffer. If you plan and keep everything fully operational with all your staff now, and then you don't get the [remaining funding], then you're not going to be able to last through the year,' Huang said. CDC centers are currently not allowed to move funding into the blocked programs, according to employees. If that money is not apportioned by Sept. 30, it could be returned to the Treasury, a maneuver known as a 'pocket rescission' that has drawn criticism from lawmakers in both parties. Congress in July approved the White House's official rescissions proposal to claw back $9 billion of funding for foreign aid and public broadcasting. The White House would have to send another official rescission message to Congress, which Office of Management and Budget (OMB) Director Russell Vought claims would effectively freeze the funding and cause it lapse. 'Effectively, what they're doing is keeping that money in house. We can't pull it down,' said Scott Harris, chief of the Alabama Department of Public Health and president of the Association of State and Territorial Health Officials. 'We have grants that we thought we had access to, we suddenly have different rules about how we're allowed to spend.' Asked about the status of CDC grants, the Department of Health and Human Services referred The Hill to OMB, which did not respond to multiple requests for comment. Harris said the uncertainty is 'chaos' for health departments and makes it almost impossible to predict or plan for the future. 'We never really know month to month if a program's still going to be here anymore,' Harris said. 'We have serious concerns about whether all of the money that has been awarded will be spent before the end of the fiscal year. New instructions on which types of expenditures are allowable will prevent us from supporting much of the programmatic work that the grants are designed to fund.'


The Hill
2 hours ago
- The Hill
Pesticides test MAHA-MAGA alliance
The 'Make America Healthy Again' (MAHA) movement could be on a collision course with its Republican allies over pesticides and toxic chemicals. MAHA is strongly aligned with the Trump administration, having cheered its anti-vaccine actions and food safety reforms. In general, the movement has been deeply skeptical of Big Pharma, Big Agriculture and Big Chemical. And cracks are beginning to form. MAHA-aligned groups and influencers are particularly raising alarms about provisions in a House appropriations bill that they say will shield pesticide and chemical manufacturers from accountability — and ultimately make Americans less healthy. Meanwhile, a draft of the administration's 'MAHA report' reportedly omits any calls to prevent pesticide exposure, also disappointing advocates. 'It's obvious that there are tensions within this newfound coalition between MAHA and MAGA, and there are some big issues there,' said Mary Holland, CEO of Children's Health Defense, a group that was founded by Health and Human Services Secretary Robert F. Kennedy Jr., considered the MAHA flagbearer. Conservatives have traditionally sided with big business, supporting fewer regulations on potentially toxic substances. Kennedy and his disciples, meanwhile, espouse stricter environmental protections, while also bucking mainstream science on vaccine safety. The disparities on chemicals and pesticides within their coalition put Republicans in the middle: Do they side with big business or health concerns? On many issues, business interests appear to be winning. The New York Times reported last week, based on a draft that it obtained, that a forthcoming iteration of the Trump administration's MAHA positions does not call for new restrictions on pesticides and describes existing procedures as 'robust.' MAHA-aligned activists recoiled. 'The MAHA draft report stating that the EPA's [Environmental Protection Agency] pesticide review process is 'robust' is the biggest joke in American history. And it's not funny. It's deadly,' wrote Zen Honeycutt, founder of the activist group Moms Across America, in a post on X. Meanwhile, a Republican-authored House Appropriations bill seeks to block pesticide labels that go beyond what the EPA uses based on its current human health risk assessment. During a markup last month, Rep. Mike Simpson (R-Idaho), who chairs the Interior-Environment Appropriations subcommittee, said that the measure says that 'states cannot require a pesticide label that is different from the EPA label.' 'The language ensures that we do not have a patchwork of state labeling requirements. It ensures that one state is not establishing the label for the rest of the states,' Simpson said, adding that his comments were meant to be clarifying for all the 'MAHA moms that are out there that are concerned about this that have been calling.' But critics say such a move could prevent the use of updated science on pesticide labels. 'This section, section 453, would basically handcuff EPA, companies and states as well as advocates to … research that could be outdated by over 15 years,' said Geoff Horsfield, policy director at the Environmental Working Group. 'The language in here … says that EPA should only update labels according to the human health risk assessment. EPA, by law, is required to do those human health risk assessments every 15 years, but they often don't complete those in time,' Horsfield said. 'The way the law works currently is states have the power to do additional addendums, and that's where you see, say, a state requires an additional setback so that you can't spray within 250 feet of a school, or you're required to wear additional types of [personal protective equipment],' he continued. 'Those types of restrictions are usually included in a label addendum, and those types of changes and those types of tweaks would be essentially prohibited by this language.' MAHA opponents have particularly expressed concerns over the implications that barring such labeling could have on the ability to sue pesticide companies over inadequate labels. 'Having no access to courts is absolutely devastating and, in my view, unconstitutional,' said Holland, with Children's Health Defense. 'I'm very distressed by this idea that this administration might, for 2026, establish liability protection.' Democrats likewise pushed back on the provision. 'This rider would effectively gag our public health agencies, preventing them from updating labels or rules to reflect new evidence of cancer risks from pesticides,' Rep. Debbie Wasserman Schultz (D-Fla.) said during the markup. 'This bill is a big middle finger to cancer patients.' Also causing controversy is another provision related to 'forever chemicals,' toxic substances that have been linked to illnesses including cancer and have become widespread in the environment. The measure seeks to bar the EPA from enforcing a draft report that found that food from farms contaminated with these chemicals may pose cancer risks. Lexi Hamel, a spokesperson for Simpson, said in an email that the bill 'prohibits funding from implementing, administering, or enforcing the current draft risk assessment due to the major technical flaws in the assessment.' But she said it does not block the EPA from 'continuing to work on identifying ways to clean up PFAS and keep communities safe' and that an amendment changed the bill so that it no longer blocks the agency from finalizing its findings. In a follow-up statement shared through a spokesperson, Horsfield said the provision is still a problem. 'The risk assessment will still have to be implemented and enforced,' he said. 'The draft risk assessment will need teeth … Allowing EPA to finalize the draft risk assessment, but preventing them from implementing it is an exercise in futility.' MAHA activists have slammed both provisions, saying in a letter to President Trump that GOP support for the measures is 'unconscionable.' However, Tony Lyons, president of the MAHA Action PAC, said he does not blame Republicans for pesticides in the environment. 'I don't think that this is something that comes from the GOP side. I think that this is a case of the Democratic Party looking to blame Republicans for it,' Lyons said. While the pesticide issues have generated some sparks between MAHA and MAGA, the administration has taken a number of other actions to also reduce restrictions on the chemical industry more broadly. Trump himself exempted from environmental standards more than 100 polluters, including chemical manufacturers, oil refineries, coal plants and medical device sterilizers. The EPA, meanwhile, has put chemical industry alumni in leading roles and has said it wants to loosen restrictions on emissions of various cancer-linked chemicals. Asked about Trump's move to exempt polluters from Clean Air Act rules, Holland said 'there's clearly tensions' within the GOP coalition. 'Those factions, if you will, more protective of corporate and more challenging to corporate, are both striving to get the president's ear, and I don't think they've come to a complete, sort of settlement agreement,' she said.
Yahoo
2 hours ago
- Yahoo
Eli Lilly (LLY) Partners with Superluminal for AI Drug Discovery
Eli Lilly and Company (NYSE:LLY) is one of the 9 Best NYSE Stocks to Buy According to Hedge Funds. On August 14, Reuters reported that Eli Lilly and Company (NYSE:LLY) has entered into a deal worth $1.3 billion with Superluminal Medicines, a privately held company. The aim of this deal is to use AI to discover and develop small-molecule drugs for obesity and other cardiometabolic diseases. As per the report by Reuters, Eli Lilly and Company (NYSE:LLY) is already leading the obesity treatment market, which is expected to be worth $150 billion by the next decade. The company is looking to solidify its foothold in this area by developing next-generation drugs, making acquisitions, and entering into partnerships. The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates discovered with the help of Superluminal's proprietary AI-driven platform targeting G-protein-coupled receptors (GPCR). These proteins can influence physiological processes including metabolism, cell growth, and immune responses. Eli Lilly and Company (NYSE:LLY) is an American multinational pharmaceutical company focused on discovering, developing, and delivering innovative medicines. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Revenue Growth Stocks to Buy Now and 14 Best Aggressive Growth Stocks to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey.